Search

everythinglearnresearchcommunity

for

Search:↓

Chemotherapy often causes skin, nail, and hair side effects, significantly impacting quality of life.

Some breast cancer patients on hormonal therapy may develop male or female pattern hair loss, which can sometimes be improved with topical treatments.

Gemcitabine and paclitaxel are effective and safe as first-line treatment for metastatic breast cancer.

Preventive measures and effective management are crucial for reducing skin side effects in cancer treatment.

Patients with metastatic breast cancer treated with epirubicin and docetaxel had a good response and maintained their quality of life.

Patients with HR+/HER2- advanced breast cancer commonly experience fatigue, hair loss, and pain, which significantly affect daily activities.

Certain hair straighteners and dyes may increase ovarian cancer risk, especially in African American/Black women.

The document concludes that blocking the internal pathways that create androgens might help treat cancers that depend on sex hormones.

Paclitaxel is an effective cancer drug with side effects and potential new uses beyond cancer.

RANK is a key target in breast cancer treatment due to its role in tumor growth and bone metastasis.

Hair loss from hormone therapy in breast cancer patients can be improved with minoxidil treatment.

Long-term estrogen therapy in postmenopausal women can improve certain health markers, hair loss is common regardless of hormone use, stopping estrogen doesn't increase breast cancer risk, smoking does, and a balanced BMI is linked to lower mortality.

Reflexology massage helps hair regrowth in women after chemotherapy.

Dermatologists should carefully manage hair loss in cancer patients to improve their quality of life.

Testosterone implants in women require pharmacological dosing to be effective and are generally safe and well-tolerated.

Deep learning helps detect skin conditions and is advancing dermatology diagnosis and treatment.

Honey and bee pollen can help reduce menopausal symptoms in breast cancer patients.

Spironolactone use is not linked to an increased risk of breast cancer, but caution is advised for high-risk patients.

New treatments for prostate cancer are less toxic and show promise, but more research is needed to enhance their effectiveness and reduce side effects.

Hair mass index is a precise way to measure hair loss in chemotherapy patients.

GLP-1 receptor agonists, like Dulaglutide, Liraglutide, and Semaglutide, have potential benefits beyond the pancreas, including neuroprotection, pain suppression, cardiovascular protection, obesity management, and cancer treatment, but there are concerns about pancreatitis and pancreatic cancer risks.

Young women in West Bengal, India, with PCOS often have estrogen resistance, leptin receptor issues, folate deficiency, T2DM, and acanthosis, commonly linked to obesity.

Keratins help protect cells, aid in cancer diagnosis, and influence cancer behavior and treatment.

The document concludes that research on sulfatase inhibitors should continue due to their potential in treating various diseases, despite some clinical trial failures.

Certain gene variants may contribute to high androgen levels in women with polycystic ovary syndrome.

Chemotherapy in the first trimester of pregnancy is risky, but in the second and third trimesters, it's generally safe with careful drug selection and timing.

A new gel form of minoxidil is equally effective for hair growth and safer for the heart and other organs than the traditional solution.

Ayurvedic herbs may reduce side effects and improve effectiveness of cancer treatments.

Certain SHBG gene variants, like rs727428, are linked to higher testosterone levels in women with PCOS.

Tamoxifen may cause female hair loss by increasing androgen receptor expression.